47 - Epetraborole

Thursday, October 20, 2022

8:20 AM – 8:30 AM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Paul B. Eckburg, MD (he/him/his)

Chief Medical Officer
AN2 Therapeutics, Inc.
Menlo Park, CA, United States

Disclosure: Disclosure(s): Adaptive Phage Therapeutics (APT): Advisor/Consultant (Ongoing); Bugworks Research: Advisor/Consultant (Ongoing); Curza: Advisor/Consultant (Ongoing); Paratek Pharmaceuticals: Safety Monitoring Board (Ongoing); SNIPR Biome: Advisor/Consultant (Terminated); Spero Therapeutics: Advisor/Consultant (Terminated)

Disclosure(s):

Paul B. Eckburg, MD: Adaptive Phage Therapeutics (APT): Advisor/Consultant (Ongoing); Bugworks Research: Advisor/Consultant (Ongoing); Curza: Advisor/Consultant (Ongoing); Paratek Pharmaceuticals: Safety Monitoring Board (Ongoing); SNIPR Biome: Advisor/Consultant (Terminated); Spero Therapeutics: Advisor/Consultant (Terminated)